Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy-Reference-Cited by-同舟云学术

Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy

Published:2015-03-27 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Snyder Kimberly A,Hughes Michael R,Hedberg Bradley,Brandon Jill,Hernaez Diana Canals,Bergqvist Peter,Cruz Frederic,Po Kelvin,Graves Marcia L,Turvey Michelle E,Nielsen Julie S,Wilkins John A,McColl Shaun R,Babcook John S,Roskelley Calvin D,McNagny Kelly M

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0562-7.pdf

Reference37 articles.

1. Weigelt B, Peterse JL, van ’t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5:591–602.

2. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429–34.

3. Schopperle WM, DeWolf WC. The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells. 2007;25:723–30.

4. Kelley TW, Huntsman D, McNagny KM, Roskelley CD, Hsi ED. Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol. 2005;124:134–42.

5. Graf T, McNagny K, Brady G, Frampton J. Chicken “erythroid” cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent. Cell. 1992;70:201–13.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redistribution of the glycocalyx exposes phagocytic determinants on apoptotic cells;Developmental Cell;2024-04

2. Keratan sulfate, an electrosensory neurosentient bioresponsive cell instructive glycosaminoglycan;Glycobiology;2024-02-20

3. Potential biomarkers and drug targets in glycoproteome of MCF-7 breast cancer cells based on proteomics and bioinformatics strategies Running title: Protein drug targets in MCF-7 cell line;2024-01-23

4. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts;International Journal of Molecular Sciences;2023-12-21

5. A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma;Frontiers in Oncology;2023-12-21